Caroline was awarded a Lister Institute of Preventative Medicine Research Fellowship before moving to the CRUK Manchester Institute in 2003. Here she set up the Clinical and Experimental Pharmacology Group interfacing with the Derek Crowther Unit for early clinical trials at The Christie. Professor Michael Douek Professor of Surgical Oncology King's College London and Honorary Consultant Surgeon at Guy's and St Thomas' Hospital Michael is a breast cancer surgeon with a research interest in developing and evaluating novel techniques for cancer surgery. He developed a novel magnetic technique for sentinel node biopsy and breast lesion localisation, is one of the pioneers of intra-operative radiotherapy for breast cancer and is the chief investigator of several international surgical device trials. In 2003, he was awarded a Health Foundation Clinician Scientist by the UK Academy of Medical Sciences funding his Senior Lecturer post at UCL. In 2015, he was awarded a prestigious Hunterian Professorship by the Royal College of Surgeons of England. Professor Jeff Evans ECMC Lead and Professor of Translational Cancer Research, Head of Experimental Therapeutics Unit and Director of the Institute of Cancer Sciences, University of Glasgow Jeff’s clinical interests are in upper GI, pancreatic cancer and melanoma. He focuses on the preclinical and clinical development of novel anti-cancer agents including molecular targeted therapies. Jeff also leads the Phase I clinical trials and drug development team in Glasgow and is a member of the AZ ECMC Combinations Alliance Steering Committee. –
Caroline was awarded a Lister Institute of Preventative Medicine Research Fellowship before moving to the CRUK Manchester Institute in 2003. Here she set up the Clinical and Experimental Pharmacology Group interfacing with the Derek Crowther Unit for early clinical trials at The Christie. Professor Michael Douek Professor of Surgical Oncology King's College London and Honorary Consultant Surgeon at Guy's and St Thomas' Hospital Michael is a breast cancer surgeon with a research interest in developing and evaluating novel techniques for cancer surgery. He developed a novel magnetic technique for sentinel node biopsy and breast lesion localisation, is one of the pioneers of intra-operative radiotherapy for breast cancer and is the chief investigator of several international surgical device trials. In 2003, he was awarded a Health Foundation Clinician Scientist by the UK Academy of Medical Sciences funding his Senior Lecturer post at UCL. In 2015, he was awarded a prestigious Hunterian Professorship by the Royal College of Surgeons of England. Professor Jeff Evans ECMC Lead and Professor of Translational Cancer Research, Head of Experimental Therapeutics Unit and Director of the Institute of Cancer Sciences, University of Glasgow Jeff’s clinical interests are in upper GI, pancreatic cancer and melanoma. He focuses on the preclinical and clinical development of novel anti-cancer agents including molecular targeted therapies. Jeff also leads the Phase I clinical trials and drug development team in Glasgow and is a member of the AZ – ECMC Combinations Alliance Steering Committee.
JING%20delegate%20biographies%20final%20CAITLIN_0.docx